Dose-Ranging Study of Multiple Subcutaneous Doses of LY2127399, an Anti-BAFF Human Antibody, in Participants with Active Rheumatoid Arthritis despite Ongoing Methotrexate Therapy.
Year: 2010
Type: Musculoskeletal
Phase: II
Indication: Rheumatoid Arthritis
A Multi-Centre, Randomised, Double-Blind, Placebo Controlled, Parallel Group Exploratory Study to Investigate the Efficacy, Safety and Tolerability of AD 337 in the Treatment of Fibromyalgia in Female Subjects.
Year: 2007
Type: Musculoskeletal
Phase: II
Indication: Fibromyalgia
A Randomized, Observer-Blind with Single-Blind Booster, Multi Centre, Study to Evaluate Safety, Tolerability and Immunogenicity of an Adjuvanted Cell Culture-Derived H5N1 Subunit Influenza Virus Vaccine at Two Different Formulations in Healthy Adult and Elderly Subjects.
Year: 2013
Type: Vaccine
Phase: II
Indication: Healthy
A Double Blind, Randomised, Parallel Group, Dose-Ranging Study Comparing FX006 to Commercially Available Triamcinolone Acetonide Injectable Suspension in Patients with Osteoarthritis of the Knee.
Year: 2012
Type: Musculoskeletal
Phase: II
Indication: Knee Osteoarthritis
A randomised, double-blind using blinded evaluator, placebo and active controlled, pilot study to evaluate the safety and efficacy of intra articular administration of Articul One in patient with symptomatic primary knee osteoarthritis.
Year: 2017
Type: Musculoskeletal
Phase: II
Indication: Knee Osteoarthritis
Buffered GEnipin Microinvasive Device for Treatment of Low Back Pain from Degenerative Disc Disease – CE Marking Safety and Efficacy Study (GEM-SE).
